Reanalyses of Randomized Clinical Trial Data

被引:127
|
作者
Ebrahim, Shanil [1 ,2 ,3 ,4 ]
Sohani, Zahra N. [2 ,5 ]
Montoya, Luis [6 ]
Agarwal, Arnav [7 ]
Thorlund, Kristian [1 ,2 ]
Mills, Edward J. [1 ,2 ,8 ]
Ioannidis, John P. A. [1 ,9 ,10 ,11 ]
机构
[1] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[3] McMaster Univ, Dept Anesthesia, Hamilton, ON L8S 4L8, Canada
[4] Hosp Sick Children, Dept Anaesthesia & Pain Med, Toronto, ON M5G 1X8, Canada
[5] McMaster Univ, Populat Genom Program, Hamilton, ON L8S 4L8, Canada
[6] Univ Hlth Network, Toronto, ON, Canada
[7] McMaster Univ, Fac Hlth Sci, Hamilton, ON L8S 4L8, Canada
[8] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada
[9] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[10] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA
[11] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA
来源
基金
加拿大健康研究院;
关键词
PERIPHERAL NEUROPATHY; EFFICACY CRITERIA; NATIONAL-SURVEY; ACUPUNCTURE; GENETICS; SCIENCE; DISEASE; MODEL;
D O I
10.1001/jama.2014.9646
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Reanalyses of randomized clinical trial (RCT) data may help the scientific community assess the validity of reported trial results. OBJECTIVES To identify published reanalyses of RCT data, to characterize methodological and other differences between the original trial and reanalysis, to evaluate the independence of authors performing the reanalyses, and to assess whether the reanalysis changed interpretations from the original article about the types or numbers of patients who should be treated. DESIGN We completed an electronic search of MEDLINE from inception to March 9, 2014, to identify all published studies that completed a reanalysis of individual patient data from previously published RCTs addressing the same hypothesis as the original RCT. Four data extractors independently screened articles and extracted data. MAIN OUTCOMES AND MEASURES Changes in direction and magnitude of treatment effect, statistical significance, and interpretation about the types or numbers of patients who should be treated. RESULTS We identified 37 eligible reanalyses in 36 published articles, 5 of which were performed by entirely independent authors (2 based on publicly available data and 2 on data that were provided on request; data availability was unclear for 1). Reanalyses differed most commonly in statistical or analytical approaches (n = 18) and in definitions or measurements of the outcome of interest (n = 12). Four reanalyses changed the direction and 2 changed the magnitude of treatment effect, whereas 4 led to changes in statistical significance of findings. Thirteen reanalyses (35%) led to interpretations different from that of the original article, 3 (8%) showing that different patients should be treated; 1 (3%), that fewer patients should be treated; and 9 (24%), that more patients should be treated. CONCLUSIONS AND RELEVANCE A small number of reanalyses of RCTs have been published to date. Only a few were conducted by entirely independent authors. Thirty-five percent of published reanalyses led to changes in findings that implied conclusions different from those of the original article about the types and number of patients who should be treated.
引用
收藏
页码:1024 / 1032
页数:9
相关论文
共 50 条
  • [11] Augmenting randomized clinical trial data with historical control data: Precision medicine applications
    Freidlin, Boris
    Korn, Edward L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (01): : 14 - 20
  • [12] Sepsis Phenotyping Using Clinical and Biomarker Data in the ProCESS Randomized Trial
    DeMerle, K. M.
    Angus, D. C.
    Chang, C. H.
    Delucchi, K.
    Huang, D. T.
    Kennedy, J. N.
    Shapiro, N. I.
    Yealy, D. M.
    Calfee, C. S.
    Seymour, C. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [14] When to base clinical policies on observational versus randomized trial data
    Hornberger, J
    Wrone, E
    ANNALS OF INTERNAL MEDICINE, 1997, 127 (08) : 697 - 703
  • [15] Assessing quality of life in a randomized clinical trial: Correcting for missing data
    Nina Gunnes
    Taral G Seierstad
    Steinar Aamdal
    Paal F Brunsvig
    Anne-Birgitte Jacobsen
    Stein Sundstrøm
    Odd O Aalen
    BMC Medical Research Methodology, 9
  • [16] Assessing quality of life in a randomized clinical trial: Correcting for missing data
    Gunnes, Nina
    Seierstad, Taral G.
    Aamdal, Steinar
    Brunsvig, Paal F.
    Jacobsen, Anne-Birgitte
    Sundstrom, Stein
    Aalen, Odd O.
    BMC MEDICAL RESEARCH METHODOLOGY, 2009, 9
  • [17] Analysis of randomized comparative clinical trial data for personalized treatment selections
    Cai, Tianxi
    Tian, Lu
    Wong, Peggy H.
    Wei, L. J.
    BIOSTATISTICS, 2011, 12 (02) : 270 - 282
  • [18] Validation of the UVA Simulation Replay Methodology Using Clinical Data: Reproducing a Randomized Clinical Trial
    Villa-Tamayo, Maria F.
    Colmegna, Patricio
    Breton, Marc
    DIABETES TECHNOLOGY & THERAPEUTICS, 2024,
  • [19] Clinical trial variability: Quality control in a randomized clinical trial
    McGregor, Marion
    Cambron, Jerrilyn A.
    Jedlicka, James
    Gudavalli, M. Ram
    Contemporary Clinical Trials, 2009, 30 (01) : 20 - 23
  • [20] Validation of the UVA Simulation Replay Methodology Using Clinical Data: Reproducing a Randomized Clinical Trial
    Villa-Tamayo, Maria F.
    Colmegna, Patricio
    Breton, Marc
    DIABETES TECHNOLOGY & THERAPEUTICS, 2024, 26 (10) : 720 - 727